Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter F Zipfel

Showing results (161-170 of 273) with videos related to

Pageof 28
Sort By:
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|February 3, 2005
Successful plasma therapy for atypical hemolytic uremic syndrome caused by factor H deficiency owing to a novel mutation in the complement cofactor protein domain 15Christoph Licht, Annic Weyersberg, Stefan Heinen, et al.
International Journal of Oncology|April 20, 2011
Human complement factor H is a novel diagnostic marker for lung adenocarcinomaTiantian Cui, Yuan Chen, Thomas Knösel, et al.
Scientific Reports|April 7, 2022
Low molecular weight polysialic acid binds to properdin and reduces the activity of the alternative complement pathwayAnahita Shahraz, Yuchen Lin, Joshua Mbroh, et al.
Kidney International Reports|June 11, 2020
<i>In situ</i> Visualization of C3/C5 Convertases to Differentiate Complement ActivationFermin Person, Tim Petschull, Sonia Wulf, et al.
Pediatric Nephrology (Berlin, Germany)|July 2, 2003
Successful (?) therapy of hemolytic-uremic syndrome with factor H abnormalityAngela Gerber, Antje H Kirchhoff-Moradpour, Silke Obieglo, et al.
Journal of the American Society of Nephrology : JASN|February 7, 2001
The molecular basis of familial hemolytic uremic syndrome: mutation analysis of factor H gene reveals a hot spot in short consensus repeat 20Jessica Caprioli, Paola Bettinaglio, Peter F Zipfel, et al.
Clinical Kidney Journal|August 11, 2018
Membranoproliferative glomerulonephritis and C3 glomerulopathy in children: change in treatment modality? A report of a case seriesGiuseppina Spartà, Ariana Gaspert, Thomas J Neuhaus, et al.
International Journal of Medical Microbiology : IJMM|August 19, 2008
Identification and characterization of the factor H and FHL-1 binding complement regulator-acquiring surface protein 1 of the Lyme disease spirochete Borrelia spielmanii sp. novPia Herzberger, Corinna Siegel, Christine Skerka, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 17, 2012
Yersinia enterocolitica YadA mediates complement evasion by recruitment and inactivation of C3 productsMagnus K H Schindler, Monika S Schütz, Melanie C Mühlenkamp, et al.
Kidney International|July 18, 2008
C3 deposition glomerulopathy due to a functional factor H defectSandra Habbig, Michael J Mihatsch, Stefan Heinen, et al.
Pageof 28

Showing results (161-170 of 273) with videos related to

Sort By:
Pageof 28
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|February 3, 2005
Successful plasma therapy for atypical hemolytic uremic syndrome caused by factor H deficiency owing to a novel mutation in the complement cofactor protein domain 15Christoph Licht, Annic Weyersberg, Stefan Heinen, et al.
International Journal of Oncology|April 20, 2011
Human complement factor H is a novel diagnostic marker for lung adenocarcinomaTiantian Cui, Yuan Chen, Thomas Knösel, et al.
Scientific Reports|April 7, 2022
Low molecular weight polysialic acid binds to properdin and reduces the activity of the alternative complement pathwayAnahita Shahraz, Yuchen Lin, Joshua Mbroh, et al.
Kidney International Reports|June 11, 2020
<i>In situ</i> Visualization of C3/C5 Convertases to Differentiate Complement ActivationFermin Person, Tim Petschull, Sonia Wulf, et al.
Pediatric Nephrology (Berlin, Germany)|July 2, 2003
Successful (?) therapy of hemolytic-uremic syndrome with factor H abnormalityAngela Gerber, Antje H Kirchhoff-Moradpour, Silke Obieglo, et al.
Journal of the American Society of Nephrology : JASN|February 7, 2001
The molecular basis of familial hemolytic uremic syndrome: mutation analysis of factor H gene reveals a hot spot in short consensus repeat 20Jessica Caprioli, Paola Bettinaglio, Peter F Zipfel, et al.
Clinical Kidney Journal|August 11, 2018
Membranoproliferative glomerulonephritis and C3 glomerulopathy in children: change in treatment modality? A report of a case seriesGiuseppina Spartà, Ariana Gaspert, Thomas J Neuhaus, et al.
International Journal of Medical Microbiology : IJMM|August 19, 2008
Identification and characterization of the factor H and FHL-1 binding complement regulator-acquiring surface protein 1 of the Lyme disease spirochete Borrelia spielmanii sp. novPia Herzberger, Corinna Siegel, Christine Skerka, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 17, 2012
Yersinia enterocolitica YadA mediates complement evasion by recruitment and inactivation of C3 productsMagnus K H Schindler, Monika S Schütz, Melanie C Mühlenkamp, et al.
Kidney International|July 18, 2008
C3 deposition glomerulopathy due to a functional factor H defectSandra Habbig, Michael J Mihatsch, Stefan Heinen, et al.
Pageof 28